These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1982653)

  • 1. Is blockade of alpha 1-adrenoceptors favourable in hypotension induced by stimulation of serotonin1A receptors in conscious dogs?
    Beller KD; Boer R; Sanders KH; Walter B
    Drugs; 1990; 40 Suppl 4():38-41. PubMed ID: 1982653
    [No Abstract]   [Full Text] [Related]  

  • 2. Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.
    Kolassa N; Beller KD; Sanders KH
    Am J Cardiol; 1989 Aug; 64(7):7D-10D. PubMed ID: 2569265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of central nervous system serotonin-1A receptors for mediating the hypotensive effect of urapidil.
    Mandal AK; Kellar KJ; Friedman E; Pineo SV; Hamosh P; Gillis RA
    J Pharmacol Exp Ther; 1989 Nov; 251(2):563-70. PubMed ID: 2530339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects in the Sprague-Dawley rat of 8-hydroxy-2(di-N-propylamino) tetralin, a selective 5-hydroxytryptamine receptor agonist.
    Gradin K; Pettersson A; Hjorth S; Hedner T; Arvidsson LE; Persson B
    J Pharm Pharmacol; 1985 Apr; 37(4):263-5. PubMed ID: 2860226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of urapidil with brain serotonin-1A receptors increases the blood pressure reduction due to peripheral alpha-adrenoceptor inhibition.
    Sanders KH; Beller KD; Bischler P; Kolassa N
    J Hypertens Suppl; 1988 Dec; 6(2):S65-8. PubMed ID: 2906703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 1-adrenoceptor blockade and/or 5-HT1A agonism during treadmill exercise in dogs.
    Grohs JG; Fischer G; Huber S; Raberger G
    J Auton Pharmacol; 1991 Apr; 11(2):101-7. PubMed ID: 1675216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of 5-HT1A receptors in blood pressure reduction by 8-OH-DPAT and urapidil in cats.
    Sanders KH; Beller KD; Kolassa N
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S86-93. PubMed ID: 1702492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are drugs that act both on serotonin receptors and alpha 1-adrenoceptors more potent hypotensive agents than those that act only on alpha 1-adrenoceptors?
    Ramage AG
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S30-4. PubMed ID: 2459511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous actions of serotonin and a serotonin1A receptor agonist: cardiovascular excitation at low doses.
    Dedeoğlu A; Fisher LA
    J Pharmacol Exp Ther; 1991 Apr; 257(1):425-32. PubMed ID: 1826928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat.
    Deckert V; Chaouloff F; Richer C; Elghozi JL
    Arch Int Pharmacodyn Ther; 1990; 306():114-29. PubMed ID: 1981665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats.
    Docherty JR
    J Pharmacol Exp Ther; 1989 Feb; 248(2):736-40. PubMed ID: 2537414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in conscious dogs.
    Di Francesco GF; Petty MA; Fozard JR
    Eur J Pharmacol; 1988 Mar; 147(2):287-90. PubMed ID: 2966743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT1A-agonistic properties of naftopidil, a novel antihypertensive drug.
    Borbe HO; Metzenauer P; Szelenyi I
    Eur J Pharmacol; 1991 Nov; 205(1):105-7. PubMed ID: 1839829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency selective compounds and inhibition of cardiovascular reflexes.
    Park KH; Long JP; Cannon JG
    J Pharmacol Exp Ther; 1990 Oct; 255(1):240-7. PubMed ID: 2145423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central and peripheral hypotensive activity of urapidil and its M1 and M2 metabolites in the cat.
    Boss H; Boer R; Beller KD; Sanders KH
    Drugs; 1990; 40 Suppl 4():34-7. PubMed ID: 1982652
    [No Abstract]   [Full Text] [Related]  

  • 16. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade.
    Constantine JW; Lebel W; Weeks R
    J Cardiovasc Pharmacol; 1984; 6(1):142-50. PubMed ID: 6199597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive drugs: proposed sites and mechanisms of action.
    Kaplan HR; Smith RD
    Fed Proc; 1981 Jun; 40(8):2268-74. PubMed ID: 6113170
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of reflex tachycardia by central administration of the alpha-1 adrenoceptor antagonists urapidil and prazosin in anesthetized dogs.
    Shebuski RJ; Zimmerman BG
    J Pharmacol Exp Ther; 1985 Aug; 234(2):456-62. PubMed ID: 2862276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of reflex tachycardia following alpha-adrenoceptor blockade in conscious dogs: comparison of urapidil with prazosin.
    Shebuski RJ; Zimmerman BG
    J Cardiovasc Pharmacol; 1984; 6(5):788-94. PubMed ID: 6209481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects following injection of 8-OH-DPAT and flesinoxan into the dorsal raphe nucleus of conscious rats.
    Connor HE; Higgins GA
    Br J Pharmacol; 1989 Dec; 98 Suppl():810P. PubMed ID: 2532943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.